Palonosetron effectively prevents emesis and nausea induced by high dose chemotherapy in patients undergoing autologous stem cell transplantation
Lugano/Berlin, Germany (ots) - Single dose palonosetron achieves optimal control of acute emesis in patients receiving multiday-high dose chemotherapy before autologous stem cell transplantation. The addition of a second dose of palonosetron after 48 hours significantly reduces the detrimental impact of ...